Methods for promoting functional regeneration of mammalian muscle by administering leukaemia inhibitor factor
Patent Number: 6093390
Date of First Priority Issue: Tuesday March 20th, 1990
Date Issued: Tuesday July 25th, 2000
Assignee: Amrad Corporation Limited (Victoria, AU)
Inventors: Bartlett, Perry (North Carlton, AU); Murphy, Mark (Fitzroy, AU); Brown, Melissa (London, GB)
From Class: Expansion
Comments: No comments
This patent teaches that LIF may be used alone, or in combination with neurotrophic factors for the stimulation of neurogenesis and muscle innervation. This patent may be useful for combining with exogenous stem cell sources such as cord blood. Additionally, the patent may be used for treating patients with multiple sclerosis.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.